Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer

NCT02768415 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Apatinib
DRUG: Oral Vinorelbine

Sponsor

Chinese Academy of Medical Sciences